Cipher Pharmaceuticals Inc. (CPHRF) Stock Overview
Explore Cipher Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cipher Pharmaceuticals Inc. (CPHRF)
Key Financials
Key Financials
Market Cap
299.6M
P/E Ratio
9.67
EPS (TTM)
$1.19
ROE
0.26%
CPHRF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cipher Pharmaceuticals Inc. (CPHRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 38.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.67 and a market capitalization of 299.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.